AzTrials
AzTrials

Endometriosis, RectumENDO-SHAVINGNCT04411004

Persistence Disease After Laparoscopic Shaving of Rectal Endometriosis

An observational study of Endometriosis, Rectum, run by Ospedale Policlinico San Martino at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

When performing shaving of a rectal endometriotic nodule, the surgeon can use the macroscopic appearance of the nodule and the tactile feedback provided by the laparoscopic instruments to decide the area of the bowel that needs to be excised. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Endometriosis, Rectum
What is being tested?
Transvaginal ultrasound and 5-point Likert scale
How many people
100 participants
Where
1 siteItaly
Study dates
1 May 2017to 1 Jan 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients underwent shaving of rectal endometriosis

Who may be able to join

  • patients underwent laparoscopic shaving of rectovaginal endometriosis infiltrating the rectum

Who cannot join

  • patients underwent previous bowel surgery (except appendectomy);
  • patients experienced postoperative complications (such as pelvic abscess, rectovaginal fistula, ureteral injuries)

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Ospedale Policlinico San Martino

    Genoa, 16132

Other trials in Italy

About this study

Official title: Persistence of Rectal Endometriosis After Laparoscopic Shaving of Rectovaginal Endometriosis Infiltrating the Rectum

When performing shaving of a rectal endometriotic nodule, the surgeon can use the macroscopic appearance of the nodule and the tactile feedback provided by the laparoscopic instruments to decide the area of the bowel that needs to be excised. Theoretically, compared with segmental bowel resection, the shaving technique may expose the patients to a higher risk of persistence of intestinal endometriosis. The objective of this ultrasonographic study was to assess the risk of rectal endometriosis persistence following laparoscopic shaving of rectovaginal nodules.

Being tested
Transvaginal ultrasound, 5-point Likert scale
Medical subject headings
Endometriosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transvaginal ultrasoundDiagnostic test

    Transvaginal ultrasonographic scan to diagnosis the recurrence of rectal endometriosis

  • 5-point Likert scaleBehavioural

    Subjective scale to evaluate satisfaction to previous surgical treatment for rectal endometriosis

Study groups in NCT04411004
Study groupRoleWhat they receive
Women who underwent shaving for rectal endometriosisNot described
Receives: Diagnostic Test: Transvaginal ultrasound; Behavioral: 5-point Likert scale

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with rectal recurrence of endometriosis

    Evaluated by ultrasound

    Measured: 3 months after the surgical approach

  2. Number of patients with rectal recurrence of endometriosis

    Evaluated by ultrasound

    Measured: 6 months after the surgical approach

Secondary outcomes (4)
  1. Satisfaction of patients to the previous surgical treatment

    Evaluated by five-point Likert scale

    Measured: 3 months after the surgical approach

  2. Volume of nodules in patients with rectal recurrence of endometriosis

    Evaluated by ultrasound

    Measured: 3 months after the surgical approach

  3. Satisfaction of patients to the previous surgical treatment

    Evaluated by five-point Likert scale

    Measured: 6 months after the surgical approach

  4. Volume of nodules in patients with rectal recurrence of endometriosis

    Evaluated by ultrasound

    Measured: 6 months after the surgical approach

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2020
  2. Study start1 May 2017
  3. Primary completion30 Nov 2019
  4. Study completion1 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04411004
Sponsor's protocol ID
ENDO-SHAVING
Acronym
ENDO-SHAVING
Status last verified
Nov 2020
First submitted
19 May 2020
Last updated
18 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Alhayo S, Leonardi M, Lu C, Gosal P, Reid S, Barto W, Condous G. Ultrasound evaluation of pouch of Douglas obliteration and rectal deep endometriosis in women who have had previous combined colorectal and gynaecological laparoscopic surgery for rectal endometriosis: A pilot study. Aust N Z J Obstet Gynaecol. 2020 Apr;60(2):258-263. doi: 10.1111/ajo.13112. Epub 2020 Jan 9.

    PubMed 31919838

Questions about this trial

What is this clinical trial studying?

An observational study of Endometriosis, Rectum, run by Ospedale Policlinico San Martino at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with rectal recurrence of endometriosis (time frame: 3 months after the surgical approach). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04411004, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
ENDO-SHAVING Clinical Trial NCT04411004 | AzTrials